The AlphaLISA™ SureFire® Ultra™ Human Total IRF1 assay is a sandwich immunoassay for quantitative detection of total IRF1 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | Cell Signaling |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human Total IRF1 assay is a sandwich immunoassay for quantitative detection of total IRF1 in cellular lysates using Alpha Technology.
Loading...
Interferon Regulatory Factor 1 (IRF1) is a transcription factor and founding member of the IRF family that plays central roles in innate immunity, antiviral defense, and tumor suppression. IRF1 is transcriptionally induced by interferons, cytokines, and pathogen-associated signals, and binds interferon-stimulated response elements (ISREs) and interferon regulatory factor response elements (IRF-Es) to drive expression of antiviral effectors, MHC class I/II molecules, and pro-apoptotic genes. IRF1 functions as a downstream target of STAT1 signaling and is itself a key amplifier of interferon-stimulated gene (ISG) expression, establishing a positive feedback loop in antiviral immunity. In cancer, IRF1 acts predominantly as a tumor suppressor by promoting apoptosis, inhibiting cell cycle progression, and enhancing immune surveillance through upregulation of antigen presentation machinery. Loss of IRF1 expression or function has been documented in leukemias, gastric cancer, and esophageal cancer, and is associated with immune evasion and poor prognosis. IRF1 also plays a role in regulating PD-L1 expression, positioning it at the intersection of innate immunity and immune checkpoint biology.
The AlphaLISA SureFire Ultra Human Total IRF1 Detection Kit is a sandwich immunoassay for the quantitative detection of total IRF1 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
AlphaLISA SureFire Ultra kits can be used for:
The Total-AlphaLISA SureFire Ultra assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire Ultra quality.
THP-1 cells were seeded in a 96-well plate (200,000 cells/well) in complete medium at 37°C, 5% CO2. The cells were treated with increasing concentrations of IFNβ or IFNγ for 4 hours.
After treatment, the cells were washed with HBSS and lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). IRF1 and ERK Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 20,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, treatment with IFNβ or IFNγ induced expression of IRF1 with no change to Total ERK levels.
A431 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium at 37°C, 5% CO2. The cells were treated with increasing concentrations of IFNβ or IFNγ for 4 hours.
After treatment, cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). IRF1 and ERK Total levels were evaluated using AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, treatment with IFNβ or IFNγ induced expression of IRF1 with no change to ERK Total levels.
IRF1 levels were assessed in A549 wild type (WT) and IRF1 KO (Abcam, ab267042) cell lines cultured to confluency in T175 flasks at 37°C, 5% CO2 and treated with 10 ng/mL of IFNβ for 4 hours.
Each flask was lysed with 6 mL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm) and IRF1 levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of lysate (approximately 20,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
IRF1 was detected in WT cells but not in KO cells, confirming the specificity of this assay for IRF1 protein.
Adherent cells were cultured to confluence in T175 flasks at 37°C, 5% CO2 and lysed with Lysis Buffer at a density of 200,000 cells/mL. Suspension cells were harvested, washed in HBSS and lysed with Lysis Buffer to a final density of 200,000 cells/mL.
IRF1 levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of cell lysate (approximately 20,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, basal IRF1 expression is higher in A431, Jurkat and RPMI 8226 cells, lower levels were observed in HeLa, A549 and U937 cells.
Cell lysate was prepared from THP-1 cells treated with 10 ng/mL of IFNγ for 4 hours at 1 x 106 cells/mL. After treatment, cells were washed with HBSS and lysed at a final density of 2 x 106 cells/mL.
Lysates were serially diluted and IRF1 levels were evaluated using AlphaLISA SureFire Ultra. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells/datapoint is indicated on the graph. The assay can detect IRF1 expression in less than 300 cells. Assay background is represented by the dotted line.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
IRF1
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
|
| Technology |
Alpha
|
| Therapeutic Area |
Inflammation
Oncology
|
| Unit Size |
50,000 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
Loading...
We are here to answer your questions.